• Apr 01, 2019 | Webinar

    ASBMR Webinar: Should Vertebral Augmentation be Paused? A Webinar on the Second ASBMR Task Force Report on the Efficacy and Safety of Vertebral Augmentation

    Peter Ebeling, MBBS, MD

    Vertebral compression fractures are highly prevalent in patients with osteoporosis and approximately 750,000 new fractures occur each year in the United States alone. Acute and chronic back pain occur in approximately one-third of patients with vertebral fractures, resulting in disability and impaired quality of life. Vertebral augmentation (percutaneous vertebroplasty or balloon kyphoplasty) to reduce pain in patients with symptomatic vertebral fractures was introduced into practice before high quality evidence establishing its efficacy and safety and remains in some settings part of standard routine care. Balloon kyphoplasty is currently more expensive and is performed almost three times more commonly than percutaneous vertebroplasty in the United States. 

    Educational objectives: 

    • To examine the evidence regarding the efficacy and safety of percutaneous vertebroplasty and balloon kyphoplasty for acutely painful vertebral fractures. Do benefits outweigh any harms? Which form of vertebral augmentation is better? 
    • To examine the evidence of non-pharmacological approaches such as spinal bracing and exercise for acutely painful vertebral fractures. Do either have benefits for improving functional outcomes in these patients?
    • Determine if the evidence provided by the Task Force report influences the clinical management of patients with acutely painful vertebral fractures.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details